Zigler CK - Search Results

1

Exploring the impact of paediatric localized scleroderma on health-related quality of life: focus groups with youth and caregivers.

Zigler CK, Ardalan K, Hernandez A, Caliendo AE, Magee KE, Terry MA, Mann CM, Torok KS. Zigler CK, et al. Br J Dermatol. 2020 Oct;183(4):692-701. doi: 10.1111/bjd.18879. Epub 2020 Mar 4. Br J Dermatol. 2020. PMID: 31955419

2

Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.

Ardalan K, Zigler CK, Torok KS. Ardalan K, et al. Among authors: zigler ck. Arthritis Care Res (Hoboken). 2017 Jul;69(7):1082-1087. doi: 10.1002/acr.23101. Epub 2017 Jun 7. Arthritis Care Res (Hoboken). 2017. PMID: 27696700 Free PMC article.

3

Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.

Kurzinski KL, Zigler CK, Torok KS. Kurzinski KL, et al. Among authors: zigler ck. Br J Dermatol. 2019 May;180(5):1183-1189. doi: 10.1111/bjd.17312. Epub 2018 Dec 5. Br J Dermatol. 2019. PMID: 30315656 Free PMC article.

4

A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.

Zigler CK, Ardalan K, Lane S, Schollaert KL, Torok KS. Zigler CK, et al. Br J Dermatol. 2020 Mar;182(3):625-635. doi: 10.1111/bjd.18512. Epub 2019 Oct 23. Br J Dermatol. 2020. PMID: 31498874 Free PMC article.

5

The importance of development standards for anchoring vignettes: an illustrative example from pediatric localized scleroderma quality of life.

Zigler CK, Jacobe H, Ardalan K, Coles TM, Lane S, Schollaert KL, Torok KS. Zigler CK, et al. Qual Life Res. 2020 Dec;29(12):3263-3272. doi: 10.1007/s11136-020-02575-6. Epub 2020 Jul 11. Qual Life Res. 2020. PMID: 32654054 Free PMC article.

6

A child's experience of itch: the first step towards patient-centred measures.

Zigler CK, Roberts A. Zigler CK, et al. Br J Dermatol. 2021 May;184(5):795-796. doi: 10.1111/bjd.19678. Epub 2020 Dec 15. Br J Dermatol. 2021. PMID: 33319357 No abstract available.

7

Psychometric properties of the Children's Dermatology Life Quality Index in pediatric localized scleroderma.

Ardalan K, Switzer GE, Zigler CK, Hershey NM, Torok KS. Ardalan K, et al. Among authors: zigler ck. J Scleroderma Relat Disord. 2018 Jun;3(2):175-181. doi: 10.1177/2397198318760768. Epub 2018 Mar 20. J Scleroderma Relat Disord. 2018. PMID: 35382235 Free PMC article.

8

Cross-sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (LoSQI): A disease-specific patient-reported outcome measure.

Zigler CK, Lin L, Ardalan K, Jacobe H, Lane S, Li SC, Luca NJC, Prajapati VH, Schollaert K, Teske N, Torok K. Zigler CK, et al. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1406-1414. doi: 10.1111/jdv.19059. Epub 2023 Apr 12. J Eur Acad Dermatol Venereol. 2023. PMID: 36950970

9

Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review.

Hernandez A, Zapata Leiva L, Mutka M, Torok KS, Ledbetter L, Zigler CK. Hernandez A, et al. Among authors: zigler ck. Pediatr Rheumatol Online J. 2024 Aug 21;22(1):77. doi: 10.1186/s12969-024-01014-x. Pediatr Rheumatol Online J. 2024. PMID: 39169409 Free PMC article. Review.

10

Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.

Ashe B, Zigler CK, Yabes J, Magee K, Kurzinski K, Torok KS. Ashe B, et al. Among authors: zigler ck. Int J Mol Sci. 2024 Sep 21;25(18):10134. doi: 10.3390/ijms251810134. Int J Mol Sci. 2024. PMID: 39337619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters